Source link : https://www.newshealth.biz/health-news/gene-editing-therapy-reduced-attacks-in-hereditary-angioedema/
A single dose of the CRISPR-based gene-editing therapy NTLA-2002 reduced angioedema attacks and led to sustained reduction in total plasma kallikrein protein levels compared with placebo in patients with hereditary angioedema, a phase II randomized trial showed. From week 1 to week 16 among 27 patients, the estimated mean monthly angioedema attack rate was 0.70 […]
Author : News Health
Publish date : 2024-10-24 15:05:51
Copyright for syndicated content belongs to the linked Source.